Trial Profile
Prospective study evaluating the early safety and efficacy of miriplatin administration by Balloon-occluded transcatheter arterial chemoembolization (B-TACE) method compared to convention TACE (C-TACE) method in hepatocellular carcinoma patients
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 08 Dec 2015
Price :
$35
*
At a glance
- Drugs Miriplatin (Primary)
- Indications Liver cancer
- Focus Adverse reactions; Therapeutic Use
- 08 Dec 2015 New trial record